Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials ( r immediate release formulation of NG2-...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> TECHNOLOGY

Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials

r immediate release formulation of NG2-73 Different sustained formulations are designated as "A" or "B"

Safety Profile

In both studies, NG2-73 was safe and well tolerated at all doses tested. One drug-related SAE was observed. The favorable safety and tolerability profile of NG2-73 observed in studies 202 and 203 was consistent with that observed in previous studies. NG2-73 has now been tested in more than 600 subjects.

Secondary Endpoints

Both studies included several secondary (exploratory) endpoints to obtain additional data on sleep onset, sleep maintenance and potential side-effects. These measures included LPS, WASO, Total Sleep Time (TST), Sleep Efficiency (SE), Wake Time During Sleep (WTDS), Digit Symbol Substitution Test (DSST) and Visual Analog Scales (VAS) on sedation. With regard to secondary endpoints, data from Study 202 - the sleep maintenance study -- were internally consistent and statistically significant with respect to sleep onset and maintenance. In this study, the controlled release formulation using matrix "A" described above generally performed best on all parameters with no next-day residual sedation effects. In study 203--the sleep onset study - sleep maintenance, as measured by the secondary endpoints described above, was not observed. In both studies, as expected, residual effects as measured by DSST, were observed in higher doses and with formulations with more prolonged release profiles.

Webcast

Neurogen will host a conference call and webcast to discuss this announcement at 8:30 ET today. The webcast will be available in the Investor Relations section of www.neurogen.com and will also be archived there. A replay of the call will be available after 1:00 pm ET today and accessible through the close of business, July 9, 2007. To replay the conference call, dial 888-286-8010, or for international callers, 617-801-6888, and use the pass code: 95330673.

About Neurogen's Insomnia Program'"/>

Page: 1 2 3 4 5 6 7 8
Related medicine technology :

1. Neurogen Proprietary Insomnia Compound Data for Two Studies Presented at Associated Professional Sleep Societies Annual Meeting
2. Neurogen Proprietary Insomnia Compound Data Presented at Associated Professional Sleep Societies Annual Meeting
3. Neurogen Proprietary Insomnia Compound Data Presented at American Psychiatric Association Annual Meeting
4. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
7. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease

Post Your Comments:

(Date:8/18/2008)...TOWN, Pa., Aug. 18 /PRNewswire-USNewswire/ -- Due ...-infected mosquitoes in,southeastern Pennsylvania,...s county partners will be stepping up efforts this... -- or are most likely to carry -- the virus., Wh... been confirmed,this year (a 27-year-old Montgomer...

(Date:8/18/2008)..., Aug. 18 /PRNewswire-USNewswire/ -- Boston Univer...t of the Center for Human Genetics, Inc.,("CHG") a...ston University,announced that CHG will no longer...d to Athena Diagnostics, Inc., These patented tes...s,related to A1555G or Connexin 26 mutations, deve...

(Date:8/18/2008)...LEM, Israel, August 18 /- O...p://www.oramed.com ), a developer,of oral delivery...led "Open,Label Study to Assess the Safety, Pharma...Oral Insulin Formulations in Healthy,Subjects," ha...h Annual,Meeting of the European Association for t...

(Date:8/18/2008)...y Leader with Strong Clinical Research Relationshi...ganizations to Lead Commercialization, SANTA CLAR...rdio, Inc.,(OTC Bulletin Board: NWCI) a cardiac d...at Vincent W. Renz has joined NewCardio as its pre...cialization effort, to include,business developmen...

Breaking Medicine Technology:Positive Mosquito Count for West Nile Virus Lead DEP, Southeastern PA Counties to Ramp up Treatment Activities 2 Positive Mosquito Count for West Nile Virus Lead DEP, Southeastern PA Counties to Ramp up Treatment Activities 3 Oramed Pharmaceuticals Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome) 2 Vincent W. Renz Joins NewCardio as President 2 Vincent W. Renz Joins NewCardio as President 3 Vincent W. Renz Joins NewCardio as President 4 VA Deploying Assessment Team to Marion Medical Center 5616 1 VA Deploying Assessment Team to Marion Medical Center 5616 2 US FDA approves ABILIFY for adolescent patients with schizophrenia 5611 1 US FDA approves ABILIFY for adolescent patients with schizophrenia 5611 2 US FDA approves ABILIFY for adolescent patients with schizophrenia 5611 3 US FDA approves ABILIFY for adolescent patients with schizophrenia 5611 4 Energy Drinks Could Pose Blood Pressure Risks 5609 1 Energy Drinks Could Pose Blood Pressure Risks 5609 2 PharmAthene and Medarex Announce Additional 240 8 Million U S Government Appropriation for Continued Development of Anthrax Therapeutic Valortim 28T 5605 1 PharmAthene and Medarex Announce Additional 240 8 Million U S Government Appropriation for Continued Development of Anthrax Therapeutic Valortim 28T 5605 2 PharmAthene and Medarex Announce Additional 240 8 Million U S Government Appropriation for Continued Development of Anthrax Therapeutic Valortim 28T 5605 3 PharmAthene and Medarex Announce Additional 240 8 Million U S Government Appropriation for Continued Development of Anthrax Therapeutic Valortim 28T 5605 4 PharmAthene and Medarex Announce Additional 240 8 Million U S Government Appropriation for Continued Development of Anthrax Therapeutic Valortim 28T 5605 5 PharmAthene and Medarex Announce Additional 240 8 Million U S Government Appropriation for Continued Development of Anthrax Therapeutic Valortim 28T 5605 6 PharmAthene and Medarex Announce Additional 240 8 Million U S Government Appropriation for Continued Development of Anthrax Therapeutic Valortim 28T 5605 7

[0] Positive Mosquito Count for West Nile Virus Lead DEP, Southeastern PA Counties to Ramp up Treatment Activities [0] Boston University and The Center for Human Genetics, Inc. Announce Change in Testing Services [0] Oramed Pharmaceuticals Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome)[0] Vincent W. Renz Joins NewCardio as President

...14, 2007 - NanoViricides,Inc. (Pink Sheets: NNVC)...ies against rabies that were presented along with ...de 2 H5N1 virus at,the 23rd Annual Symposium of th...mpa, FL, on Wednesday, May 2. (Pan American Societ... Symposium), The animal studies against rabies wer...

...- SIGA Technologies, Inc.,(NASDAQ: SIGA) announced...t guinea pig trial of its lead Lassa fever virus d...fety Level 4 conditions at,the U.S. Army Medical R...) by Dr. Kathleen Cashman under the supervision of...s hemorrhagic fever,viruses at USAMRIID for over 1...

Other Medicine Technology:Global Rabies Treatment May be Possible with NanoViricides Drugs 2 SIGA Passes First Hurdle with Lassa Fever Antiviral ST-193 2 SIGA Passes First Hurdle with Lassa Fever Antiviral ST-193 3 SIGA Passes First Hurdle with Lassa Fever Antiviral ST-193 4

Global Rabies Treatment May be Possible with NanoViricides Drugs SIGA Passes First Hurdle with Lassa Fever Antiviral ST-193

(Date:8/20/2008)...r-old Contestant Wins Trip to Little League Baseba... The National Spit Tobacco Education,Program (NSTE...st today,and encouraged young baseball players to...ddiction and the health risks of using tobacco pro...year,s slogan contest winner is,Joe Reck, a nine-y...

(Date:8/20/2008)...cently enacted Medicare Improvement Law immediatel...re Advantage insurance companies .../PRNewswire/ -- When the House and Senate,overrode...gislation,protecting Medicare beneficiaries, they ...e Advantage plans during one of the busiest months...

(Date:8/20/2008)...T CREEK, Calif., Aug. 20 /PRNewswire-FirstCall/ --... reported preliminary income from,continuing opera...f $27.5,million, or $0.76 per diluted share, inclu...er diluted share, related to provisions for store,... a 6.8 percent increase,compared with income from ...

(Date:8/20/2008)...FIELD, Mich., Aug. 20 /PRNewswire/ -- WXYZ- TV/Cha...llness Promotion will give thousands of,Detroit me...ALTHY LIVING,FOR KIDS" program. This year the prog....m. to 5 p.m. at the Charles H. Wright Museum of A...77, "Healthy Living for Kids",has provided free im...

[0] Slogan Contest Educates Young Baseball Players About the Dangers of Tobacco Use [0] Medicare Advantage Plans Struggle to Comply With New Federal Law [0] Longs Drug Stores Corporation Reports Second Quarter Results [0] WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History

...esearchers from the Autonomous University of Tamau...sal allergies//, bottle-feeding, thumb-sucking and... birth, even if it is for 4 months, could throw te...esearchers are armed to the teeth with evidence ga...

...rol software has been developed by scientists from...) and Siemens Medical Solutions //that facilitates...n using the internet by an off-site imaging expert...ote scans were better in quality than the onsite s...

...en have been found to be more irritable than their...cted by the Sleep Council in Britain. //The study ...ey woke up and they remained in that state of mind...% of the women were in a bad temper while waking u...

...arch suggests that children of couples having fert...ditions like autism and cerebral palsy. // Health...couples to conceive in the first place is probably...s, according to scientists. In addition fertility ...

Other Medicine News:Health News:Risk of autism Linked to Fertility Problems 2

The Latest Chatter behind Teeth that Stick Out Like a Sore Thumb!Remote Control MRI Scans British women more irritable than men at daybreak!!Risk of autism Linked to Fertility Problems

...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...

Medicine Products:

Meprobamate Meperidine, Urine Meningoencephalitis Panel, CSF with Reflex to HSV Type 1 & Type 2 Glycoprotein G-Specific Ab, IgG MEGX

( r immediate release formulation of NG2-...)Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials,Health